Barclays »

Larimar Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $160k 35k 4.53
2023-09-30 $20k 5.0k 3.98
2023-06-30 $170k 54k 3.13
2023-03-31 $128k 28k 4.52